Skip to main content
Erschienen in: Clinical Rheumatology 3/2020

05.11.2019 | Perspectives in Rheumatology

Lupus education for physicians and patients in a resource-limited setting

verfasst von: Sandra V. Navarra, Leonid D. Zamora, Ma. Theresa M. Collante

Erschienen in: Clinical Rheumatology | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with a wide range of manifestations and potential to affect several organ systems. Complications arise from both disease and medications especially glucocorticoids, significantly contributing to overall morbidity and mortality. SLE predominantly affects patients during their prime productive years resulting in substantial economic burden on the patient, caregivers, and society due to direct, indirect, and intangible costs. This illness burden is compounded in developing countries with limited resources due to various disparities in healthcare delivery. Physician education and practical referral and endorsement guidelines adapted to the local setting reinforce continuity and coordinated care. Likewise, patient education, self-help programs, and shared decision-making are essential best practice in the clinics. Both physician education and patient education improve overall outcomes in chronic diseases like SLE. As a developing country with very few rheumatologists and/or lupus specialists, efficient healthcare delivery for most Filipino lupus patients remains elusive. We describe our experience in confronting these challenges through development of strategies which focus on physician and patient education.

Key Points

• Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with a highly variable course, requiring specialized, individualized, and coordinated care by a healthcare team.
• Health disparities and limited resources significantly contribute to illness burden on the patient, family, and society.
• Physician education on SLE must commence at undergraduate medical school, be integrated in Internal Medicine and Pediatrics, and reinforced through specialized training in Rheumatology and related specialties.
• Patient education and empowerment are integral to improving healthcare outcomes especially in a resource-limited setting.
Literatur
1.
Zurück zum Zitat Navarra SV, Ishimori ML, Uy EA, Hamijoyo L, Sama J, James JA, Holers VM, Weisman MH (2011) Studies of Filipino patients with systemic lupus erythematosus: autoantibody profile of first-degree relatives. Lupus. 20:537–543CrossRefPubMed Navarra SV, Ishimori ML, Uy EA, Hamijoyo L, Sama J, James JA, Holers VM, Weisman MH (2011) Studies of Filipino patients with systemic lupus erythematosus: autoantibody profile of first-degree relatives. Lupus. 20:537–543CrossRefPubMed
2.
Zurück zum Zitat Vista ES, Weisman MH, Ishimori ML, Hamijoyo L, Navarra SV et al (2017) Strong viral associations with SLE among Filipinos. Lupus Sci Med 4(1):e000214CrossRefPubMedPubMedCentral Vista ES, Weisman MH, Ishimori ML, Hamijoyo L, Navarra SV et al (2017) Strong viral associations with SLE among Filipinos. Lupus Sci Med 4(1):e000214CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Lim KK, Chan M, Navarra SV, Haq SA, Lau CS (2016) Development and implementation of models of care for musculoskeletal conditions in middle-income and low-income Asian countries. Best Pract Res Clin Rheumatol 30(201):398e419 Lim KK, Chan M, Navarra SV, Haq SA, Lau CS (2016) Development and implementation of models of care for musculoskeletal conditions in middle-income and low-income Asian countries. Best Pract Res Clin Rheumatol 30(201):398e419
6.
Zurück zum Zitat Deal CL, Hooker R, Harrington T, Birnbaum N, Hogan P, Bouchery E, Klein-Gitelman M, Barr W (2007) The United States rheumatology workforce: supply and demand, 2005–2025. Arthritis Rheum 56:722–729CrossRefPubMed Deal CL, Hooker R, Harrington T, Birnbaum N, Hogan P, Bouchery E, Klein-Gitelman M, Barr W (2007) The United States rheumatology workforce: supply and demand, 2005–2025. Arthritis Rheum 56:722–729CrossRefPubMed
11.
Zurück zum Zitat Kabadi S, Yeaw J, Bacani AK, Tafesse E, Bos K, Karkare S, DeKoven M, Vina ER (2018) Healthcare resource utilization and costs associated with long-term corticosteroid exposure in patients with systemic lupus erythematosus. Lupus 27(11):1799–1809CrossRefPubMedPubMedCentral Kabadi S, Yeaw J, Bacani AK, Tafesse E, Bos K, Karkare S, DeKoven M, Vina ER (2018) Healthcare resource utilization and costs associated with long-term corticosteroid exposure in patients with systemic lupus erythematosus. Lupus 27(11):1799–1809CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Yelin E, Yazdany J, Trupin L (2017) Relationship between process of care and a subsequent increase in damage in systemic lupus erythematosus. Arthritis Care Res 69(6):927–932CrossRef Yelin E, Yazdany J, Trupin L (2017) Relationship between process of care and a subsequent increase in damage in systemic lupus erythematosus. Arthritis Care Res 69(6):927–932CrossRef
14.
Zurück zum Zitat Veñegas E, Geslani K, Navarra S (2018) Hospitalizations, renal activity and damage incur the highest medical costs among Filipino patients with systemic lupus erythematosus. Philippine J Intern Med 56(2):77–81 Veñegas E, Geslani K, Navarra S (2018) Hospitalizations, renal activity and damage incur the highest medical costs among Filipino patients with systemic lupus erythematosus. Philippine J Intern Med 56(2):77–81
15.
Zurück zum Zitat Yelin E, Trupin L, Bunde J, Yazdany J (2019) Poverty, neighborhoods, persistent stress, and systemic lupus erythematosus outcomes: a qualitative study of the patients’ perspective. Arthritis Care Res 71(3):398–405 Yelin E, Trupin L, Bunde J, Yazdany J (2019) Poverty, neighborhoods, persistent stress, and systemic lupus erythematosus outcomes: a qualitative study of the patients’ perspective. Arthritis Care Res 71(3):398–405
16.
Zurück zum Zitat Navarra SV, Tanangunan RD, Esquibel IC (2019) Lupus among Filipinos: unmet needs. Philippine J Intern Med 57(1):1–5 Navarra SV, Tanangunan RD, Esquibel IC (2019) Lupus among Filipinos: unmet needs. Philippine J Intern Med 57(1):1–5
17.
Zurück zum Zitat Tikly M, Navarra SV (2008) Lupus in the developing world - is it any different? Best Pract Res Clin Rheumatol 22(4):643–655CrossRefPubMed Tikly M, Navarra SV (2008) Lupus in the developing world - is it any different? Best Pract Res Clin Rheumatol 22(4):643–655CrossRefPubMed
18.
Zurück zum Zitat Patow C, Bryan D, Johnson G, Canaan E, Oyewo A, Panda M, Walsh E, Zaidan J (2016) Who’s in our neighborhood? Healthcare disparities experiential education for residents. Ochsner J 16:41–44PubMedPubMedCentral Patow C, Bryan D, Johnson G, Canaan E, Oyewo A, Panda M, Walsh E, Zaidan J (2016) Who’s in our neighborhood? Healthcare disparities experiential education for residents. Ochsner J 16:41–44PubMedPubMedCentral
19.
Zurück zum Zitat Katz SJ, Yacyshyn EA (2009) Attracting internal medicine trainees to rheumatology: where and when programs should focus efforts. J Rheumatol 36(12):2802–2805CrossRefPubMed Katz SJ, Yacyshyn EA (2009) Attracting internal medicine trainees to rheumatology: where and when programs should focus efforts. J Rheumatol 36(12):2802–2805CrossRefPubMed
21.
Zurück zum Zitat Gladman D, Urowitz M, Esdaile J, Pack M et al (1999) Guidelines for referral and management of systemic lupus erythematosus in adults. Arthritis Rheum 42(9):1785–1796CrossRef Gladman D, Urowitz M, Esdaile J, Pack M et al (1999) Guidelines for referral and management of systemic lupus erythematosus in adults. Arthritis Rheum 42(9):1785–1796CrossRef
22.
Zurück zum Zitat Arora S, Nika A, Trupin L, Abraham H, Block J, Sequeira W, Yazdany J, Jolly M (2018) Does systemic lupus erythematosus care provided in a lupus clinic result in higher quality of care than that provided in a general rheumatology clinic? Arthritis Care Res 70(12):1771–1777CrossRef Arora S, Nika A, Trupin L, Abraham H, Block J, Sequeira W, Yazdany J, Jolly M (2018) Does systemic lupus erythematosus care provided in a lupus clinic result in higher quality of care than that provided in a general rheumatology clinic? Arthritis Care Res 70(12):1771–1777CrossRef
23.
Zurück zum Zitat Son MBF, Sergeyenko Y, Guan H, Costenbader KH (2016) Disease activity and transition outcomes in a childhood-onset systemic lupus erythematosus cohort. Lupus 25(13):1431–1439CrossRefPubMedPubMedCentral Son MBF, Sergeyenko Y, Guan H, Costenbader KH (2016) Disease activity and transition outcomes in a childhood-onset systemic lupus erythematosus cohort. Lupus 25(13):1431–1439CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Sadun RE, Schanberg LE (2018) Transition and transfer of the patient with paediatric-onset lupus: a practical approach for paediatric and adult rheumatology practices. Lupus Sci Med 5(1):e000282CrossRefPubMedPubMedCentral Sadun RE, Schanberg LE (2018) Transition and transfer of the patient with paediatric-onset lupus: a practical approach for paediatric and adult rheumatology practices. Lupus Sci Med 5(1):e000282CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Nafradi L, Nakamoto K, Schulz PJ (2017) Is patient empowerment the key to promote adherence? A systematic review of the relationship between self-efficacy, health locus of control and medication adherence. PLoS ONE 12(10):e0186458CrossRefPubMedPubMedCentral Nafradi L, Nakamoto K, Schulz PJ (2017) Is patient empowerment the key to promote adherence? A systematic review of the relationship between self-efficacy, health locus of control and medication adherence. PLoS ONE 12(10):e0186458CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Grad R, Légaré F, Bell NR, Dickinson JA, Singh H, Moore AE, Kasperavicius D, Kretschmer KL (2017) Shared decision making in preventive health care: what it is; what it is not. Can Fam Physician 63:682–684PubMedPubMedCentral Grad R, Légaré F, Bell NR, Dickinson JA, Singh H, Moore AE, Kasperavicius D, Kretschmer KL (2017) Shared decision making in preventive health care: what it is; what it is not. Can Fam Physician 63:682–684PubMedPubMedCentral
28.
Zurück zum Zitat Mahieu M, Yount S, Ramsey-Goldman R (2016) Patient-reported outcomes in systemic lupus erythematosus. Rheum Dis Clin N Am 42(2):253–263CrossRef Mahieu M, Yount S, Ramsey-Goldman R (2016) Patient-reported outcomes in systemic lupus erythematosus. Rheum Dis Clin N Am 42(2):253–263CrossRef
29.
Zurück zum Zitat Izadi Z, Gandrup J, Katz PP, Yazdany J (2018) Patient-reported outcome measures for use in clinical trials of SLE: a review. Lupus Sci Med 5:e000279CrossRefPubMedPubMedCentral Izadi Z, Gandrup J, Katz PP, Yazdany J (2018) Patient-reported outcome measures for use in clinical trials of SLE: a review. Lupus Sci Med 5:e000279CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Wilkerson L, Fung CC, May W, Elliott D (2010) Assessing patient-centered care: one approach to health disparities education. J Gen Intern Med 25(Suppl 2):86–90CrossRefPubMedCentral Wilkerson L, Fung CC, May W, Elliott D (2010) Assessing patient-centered care: one approach to health disparities education. J Gen Intern Med 25(Suppl 2):86–90CrossRefPubMedCentral
31.
Zurück zum Zitat Kandane-Rathnayake R, Golder V, Louthrenoo W, Navarra SV, Zamora L et al (2019) Development of the Asia Pacific Lupus Collaboration cohort. Int J Rheum Dis 22(3):425–433CrossRefPubMed Kandane-Rathnayake R, Golder V, Louthrenoo W, Navarra SV, Zamora L et al (2019) Development of the Asia Pacific Lupus Collaboration cohort. Int J Rheum Dis 22(3):425–433CrossRefPubMed
32.
Zurück zum Zitat Franklyn K, Lau CS, Navarra SV, Louthrenoo W, Lateef A, Hamijoyo L, Wahono CS, Chen SL, Jin O, Morton S, Hoi A, Huq M, Nikpour M, Morand EF, Asia-Pacific Lupus Collaboration (2016) Definition and initial validation of a Lupus Low Disease Activity State (LLDAS). Ann Rheum Dis 75:1615–1621CrossRefPubMed Franklyn K, Lau CS, Navarra SV, Louthrenoo W, Lateef A, Hamijoyo L, Wahono CS, Chen SL, Jin O, Morton S, Hoi A, Huq M, Nikpour M, Morand EF, Asia-Pacific Lupus Collaboration (2016) Definition and initial validation of a Lupus Low Disease Activity State (LLDAS). Ann Rheum Dis 75:1615–1621CrossRefPubMed
33.
Zurück zum Zitat Golder V, Kandane-Rathnayake R, Hoi A, Zamora L, Navarra SV et al (2017) Association of the lupus low disease activity state (LLDAS) with health-related quality of life in a multinational prospective study. Arthritis Res Ther 19:62CrossRefPubMedPubMedCentral Golder V, Kandane-Rathnayake R, Hoi A, Zamora L, Navarra SV et al (2017) Association of the lupus low disease activity state (LLDAS) with health-related quality of life in a multinational prospective study. Arthritis Res Ther 19:62CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Golder V, Kandane-Rathnayake R, Hoi A, Zamora L, Navarra SV et al (2016) Frequency and predictors of the lupus low disease activity state in a multi-national and multi-ethnic cohort. Arthritis Res Ther 18:260CrossRefPubMedPubMedCentral Golder V, Kandane-Rathnayake R, Hoi A, Zamora L, Navarra SV et al (2016) Frequency and predictors of the lupus low disease activity state in a multi-national and multi-ethnic cohort. Arthritis Res Ther 18:260CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Haupt M, Millen S, Jänner M, Falagan D, Fischer-Betz R, Schneider M (2005) Improvement of coping abilities in patients with systemic lupus erythematosus: a prospective study. Ann Rheum Dis 64(11):1618–1623CrossRefPubMedPubMedCentral Haupt M, Millen S, Jänner M, Falagan D, Fischer-Betz R, Schneider M (2005) Improvement of coping abilities in patients with systemic lupus erythematosus: a prospective study. Ann Rheum Dis 64(11):1618–1623CrossRefPubMedPubMedCentral
Metadaten
Titel
Lupus education for physicians and patients in a resource-limited setting
verfasst von
Sandra V. Navarra
Leonid D. Zamora
Ma. Theresa M. Collante
Publikationsdatum
05.11.2019
Verlag
Springer London
Erschienen in
Clinical Rheumatology / Ausgabe 3/2020
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-019-04795-9

Weitere Artikel der Ausgabe 3/2020

Clinical Rheumatology 3/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Herzinfarkt mit 85 – trotzdem noch intensive Lipidsenkung?

16.05.2024 Hypercholesterinämie Nachrichten

Profitieren nach einem akuten Myokardinfarkt auch Betroffene über 80 Jahre noch von einer intensiven Lipidsenkung zur Sekundärprävention? Um diese Frage zu beantworten, wurden jetzt Registerdaten aus Frankreich ausgewertet.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.